Other OTC - Delayed Quote • USD
Navidea Biopharmaceuticals, Inc. (NAVB)
As of April 22 at 3:51 PM EDT. Market Open.
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -0.11 | -- | -- |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | -- | -- | 21.66M | 44.54M |
| Low Estimate | -- | -- | 21.66M | 44.54M |
| High Estimate | -- | -- | 21.66M | 44.54M |
| Year Ago Sales | -- | -- | -- | 21.66M |
| Sales Growth (year/est) | -- | -- | -- | 105.60% |
Earnings History
| CURRENCY IN USD | 3/31/2021 | 6/30/2021 | 9/30/2021 | |
|---|---|---|---|---|
| EPS Est. | -- | -0.08 | -0.08 | -0.11 |
| EPS Actual | -- | -0.11 | -0.09 | -0.08 |
| Difference | -- | -0.03 | -0.01 | 0.03 |
| Surprise % | -- | -37.50% | -12.50% | 27.30% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | -0.01 | 0.57 |
| 30 Days Ago | 0 | 0 | -0.01 | 0.57 |
| 60 Days Ago | 0 | 0 | -0.01 | 0.57 |
| 90 Days Ago | 0 | 0 | -0.01 | 0.57 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | NAVB | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 1.30% |
| Next Qtr. | -- | -- | -- | 10.60% |
| Current Year | -- | -- | -- | 5.10% |
| Next Year | -- | -- | -- | 13.40% |
| Next 5 Years (per annum) | -- | -- | -- | 11.21% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Related Tickers
BTTX Better Therapeutics, Inc.
0.0064
+4.92%
QBIO Q BioMed Inc.
0.0002
0.00%
PSTV Plus Therapeutics, Inc.
1.6550
+0.91%
GRI GRI Bio, Inc.
0.4696
+0.61%
ADXS Ayala Pharmaceuticals, Inc.
0.5720
0.00%
BCEL Atreca, Inc.
0.0710
-16.81%
EVLO Evelo Biosciences, Inc.
0.0450
+3.33%
TTNP Titan Pharmaceuticals, Inc.
7.01
0.00%
SRZN Surrozen, Inc.
9.25
-3.14%
TSOI Therapeutic Solutions International, Inc.
0.0007
+0.14%